VMAT2-IN-I HCl is a vesicular monoamine transporter-2 (VMAT2) inhibitor, with 15-fold greater affinity than GZ-793A. References: Citrome L. Reprint of: Clinical management of tardive dyskinesia: Five steps to success. J Neurol Sci. 2018 Jun 15;389:61-66. doi: 10.1016/j.jns.2018.02.037. Epub 2018 Feb 28. Review. PubMed PMID: 29519687.

纯度：≥98%

CAS：1436695-49-6